Neuropsychiatry's Role in the Postacute Sequelae of COVID-19: Report From the American Neuropsychiatric Association Committee on Research

Gaston Baslet; Selma Aybek; Simon Ducharme; Mandana Modirrousta; Timothy R Nicholson

doi:10.1176/appi.neuropsych.21080209

Neuropsychiatry's Role in the Postacute Sequelae of COVID-19: Report From the American Neuropsychiatric Association Committee on Research

J Neuropsychiatry Clin Neurosci. 2022 Fall;34(4):341-350. doi: 10.1176/appi.neuropsych.21080209. Epub 2022 May 17.

Authors

Gaston Baslet¹, Selma Aybek¹, Simon Ducharme¹, Mandana Modirrousta¹, Timothy R Nicholson¹

Affiliation

¹ Brigham and Women's Hospital, Harvard Medical School, Boston (Baslet); Bern University Hospital, Bern, Switzerland (Aybek); Department of Psychiatry, Douglas Mental Health University Institute, McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal (Ducharme); University of Manitoba, Winnipeg (Modirrousta); Institute of Psychiatry, Psychology and Neuroscience, King's College London, London (Nicholson).

PMID: 35578802
DOI: 10.1176/appi.neuropsych.21080209

Abstract

Postacute sequelae of COVID-19 can occur in patients who had only mild acute disease. A comprehensive neuropsychiatric approach reviews historical factors, provides objective assessment of symptoms, considers potential etiologies, and offers a therapeutic approach aimed at restoring premorbid functioning.

Keywords: COVID-19; Infectious Disease; Long COVID; Neuropsychiatric Assessment; PASC (Post-acute Sequelae of COVID-19).

MeSH terms

Acute Disease
COVID-19* / complications
Disease Progression
Humans
Neuropsychiatry*
United States